Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction

Stroke

Volumn 44, Issue 6, 2013, Pages 1629-1634

  Freeman, Jason W ^a   Luby, Marie ^a   Merino, José G ^a,b   Latour, Lawrence L ^a   Auh, Sungyoung ^a   Song, Shlee S ^a,c   Magadán, Alejandro ^a   Lynch, John K ^a   Warach, Steven ^a,d   Hsia, Amie W ^a,e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Johns Hopkins Community Physicians   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Acute stroke; Diffusion weighted imaging; MRI; Thrombolytic therapy; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE STROKE; DIFFUSION-WEIGHTED IMAGING; MRI; THROMBOLYTIC THERAPY; TPA;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84880145414     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000486     Document Type: Article

References (15)

1. Uchino K, Massaro L, Hammer MD. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy? Cerebrovasc Dis. 2010;29:57-61.
2. Chernyshev OY, Martin-Schild S, Albright KC, Barreto A, Misra V, Acosta I, et al. Safety of tPA in stroke mimics and neuroimaging-nega-tive cerebral ischemia. Neurology. 2010;74:1340-1345.
3. Tsivgoulis G, Alexandrov AV, Chang J, Sharma VK, Hoover SL, Lao AY, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke. 2011;42:1771-1774.
4. Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, et al. A model to prevent fbrinolysis in patients with stroke mimics. J Stroke Cerebrovasc Dis. 2012;21:839-843.
5. Giraldo EA, Khalid A, Zand R. Safety of Intravenous Thrombolysis within 4.5 h of symptom onset in patients with negative post-treatment stroke imaging for cerebral infarction. Neurocrit Care. 2011;15:76-79.
6. Luby M, Bykowski JL, Schellinger PD, Merino JG, Warach S. Intra-and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fuid-attenuated inversion recovery MRI. Stroke. 2006;37:2951-2956.
7. Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF, et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke. 2012;43:2986-2991.
8. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2000;20:937-946.
9. Li F, Silva MD, Liu KF, Helmer KG, Omae T, Fenstermacher JD, et al. Secondary decline in apparent diffusion coeffcient and neurological outcomes after a short period of focal brain ischemia in rats. Ann Neurol. 2000;48:236-244.
10. Ringer TM, Neumann-Haefelin T, Sobel RA, Moseley ME, Yenari MA. Reversal of early diffusion-weighted magnetic resonance imaging abnormalities does not necessarily refect tissue salvage in experimental cerebral ischemia. Stroke. 2001;32:2362-2369.
11. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, et al.; EPITHET-DEFUSE Investigators. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab. 2012;32:50-56.
12. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, et al. Late secondary ischemic injury in patients receiving intraarterial throm-bolysis. Ann Neurol. 2002;52:698-703.
13. Benameur K, Bykowski JL, Luby M, Warach S, Latour LL. Higher prevalence of cortical lesions observed in patients with acute stroke using high-resolution diffusion-weighted imaging. AJNR Am J Neuroradiol. 2006;27:1987-1989.
14. Kuhl CK, Textor J, Gieseke J, von Falkenhausen M, Gernert S, Urbach H, et al. Acute and subacute ischemic stroke at high-feld-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study. Radiology. 2005;234:509-516.
15. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293-298.